Abingworth exits Adaptate

Takeda has acquired UK-based Adaptate Biotherapeutics, a immunotherapy company, from Abingworth.

10 January 2022•3 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.